Abstract:This study focused on synthesizing and characterizing spherical silica, titania, and P(MAA‐EGDMA) NPs, using various analytical techniques. CIP was chosen as the drug sample. Different methods were employed to load CIP onto the NPs based on their type. Despite P(MAA‐EGDMA) showing higher CIP loading capacity, its total release amount was less than titania NPs and slightly more than silica NPs. Silica and titania exhibited lower initial release rates compared to P(MAA‐EGDMA). Antibacterial activities of the CIP‐delivery systems were evaluated against various bacteria, with titania showing potential as an antibacterial agent, particularly against P. aeruginosa. In this study, spherical silica, titania and poly(methacrylic acid‐ethylene glycol dimethacrylate) (P(MAA‐EGDMA)) nanoparticles (NPs) were synthesized and characterized by scanning electron microscopy (SEM), differential scanning calorimetry (DSC), dynamic light scattering (DLS), Fourier transform infrared (FTIR), thermogravimetric analysis (TGA), and UV spectroscopy methods. Ciprofloxacin (CIP) was selected as the drug sample for this study. The loading of CIP onto NPs was accomplished through different methods based on the type of NP used. Although P(MAA‐EGDMA) has higher CIP loading capacity compared to silica and titania nanocarriers, it was observed that the total release amount was less than titania NPs and a littele bit more than silica NPs. The CIP content of NPs was found to be approximately 7 % for both titania and silica, whereas it was observed to be 40 % for P(MAA‐EGDMA). P(MAA‐EGDMA)@CIP released 60ng of CIP over 18 hours, while silica@CIP released 38 ng over the same period. Titania@CIP released 600 ng within 6 hours, showing a tenfold increase compared to the other systems. Interestingly, silica@CIP did not start releasing CIP within 1.5 hours, whereas P(MAA‐EGDMA)@CIP released up to 50 % within the same timeframe. The antibacterial activities of all CIP‐delivery systems were thoroughly examined and compared against a range of bacteria including P. aeruginosa, E. coli, S. typhimurium, K. pneumonia, S. epidermidis, S. aureus, B. subtilis, B. cereus, and E. Faecalis. Combining titania with CIP resulted in a decrease in antibacterial effect in most bacteria, except for E. coli and S. Typhimurium, where it notably increased to 10 μg/mL. However, the combination showed effectiveness against other bacteria, albeit with a significant reduction compared to individual substance use. These results highlight titania's potential as an antibacterial agent against P. aeruginosa, with a lower MIC value compared to CIP.

Synthesis of cefixime loaded PCL/HPMC blend nanoparticles: a controlled release study and in vitro anti-bacterial evaluation

Formulation Design, Characterization and In-Vivo Assessment of Cefixime Loaded Binary Solid Lipid Nanoparticles to Enhance Oral Bioavailability.

Fabrication of CMC/PVA/Dextrin-Based Polymeric Membrane for Controlled Release of Cefixime With Enhanced Antibacterial Activity

Enhancement of bioavailability of cefpodoxime proxetil using different polymeric microparticles

Holistic Study Design Following Quality by Design Approach for Fabrication of Hybrid Polymeric Nanoparticulate Based Dry Powders as Carriers for Ciprofloxacin

Cefixime-Containing Silica Nanoseeds Coated by a Hybrid PVA-Gold Network with a Cys–Arg Dipeptide Conjugation: Enhanced Antimicrobial and Drug Release Properties

Cefixime loaded bare and functionalized halloysite nanocarriers and their biomedical applications

A Method for Efficient Loading of Ciprofloxacin Hydrochloride in Cationic Solid Lipid Nanoparticles: Formulation and Microbiological Evaluation

A Comparative Solubility Enhancement Study of Cefixime Trihydrate Using Different Dispersion Techniques

Novel formulation for co-delivery of cinnamon- and cumin-loaded polymeric nanoparticles to enhance their oral bioavailability

Fabrication of Ciprofloxacin-Loaded Sodium Alginate Nanobeads Coated with Thiol-Anchored Chitosan Using B-390 Encapsulator Following Optimization by DoE

Insight into CMC-PVA-fHNTs Nanocomposite Hydrogel as an Advance Carrier for Cefadroxil Monohydrate: Fabrication and Characterization/Angiogenic Potential Analysis

Polyelectrolyte-surfactant-complex nanoparticles as a delivery platform for poorly soluble drugs: A case study of ibuprofen loaded cetylpyridinium-alginate system

Physical Characterization and In Vitro Evaluation of Dissolution Rate from Cefpodoxime Proxetil Loaded Self Solidifying Solid SNEDDS

Formulation, Characterization, Optimization, and Pharmacokinetic Evaluation of Cilnidipine-Loaded Liquisolid Compacts with Improved Dissolution and Bioavailability

Innovative Microencapsulation of Polymyxin B for Enhanced Antimicrobial Efficacy via Coated Spray Drying

Formulation and Evaluation of pH-Modulated Amorphous Solid Dispersion-Based Orodispersible Tablets of Cefdinir

IMPROVEMENT OF BIOAVAILABILITY OF CEFUROXIME AXETIL ORAL SUSPENSION BY INCLUSION COMPLEXATION METHOD

Bioavailability Enhancement of Polymyxin B With Novel Drug Delivery: Development and Optimization Using Quality-by-Design Approach

Fabrication, physical characterizations and in vitro antibacterial activity of cefadroxil-loaded chitosan/poly(vinyl alcohol) nanofibers against Staphylococcus aureus clinical isolates

Analysis of Ciprofloxacin‐Loaded Nanoparticles (Titania, Silica, and P(MAA‐EGDMA)) for Controlled Drug Release and Improved Antibacterial Effectiveness